141 results on '"Tassinari, Melissa"'
Search Results
2. Transcriptomics analysis of early embryonic stem cell differentiation under osteoblast culture conditions: Applications for detection of developmental toxicity
3. Developing osteoblasts as an endpoint for the mouse embryonic stem cell test
4. Bugs, drugs, and the placenta
5. Cell Structure and Gene Expression: Contributions of the Extracellular Matrix to Regulation of Osteoblast Growth and Differentiation
6. Cell Structure and the Regulation of Genes Controlling Proliferation and Differentiation: The Nuclear Matrix and Cytoskeleton
7. Getting to safer and smarter medication use during pregnancy
8. Preclinical Safety Assessment: Introduction and Overview
9. A Global Regulatory Perspective
10. Clinical Outcome Assessments for Clinical Trials in Children
11. Juvenile Animal Toxicity Studies: Regulatory Expectations, Decision Strategies and Role in Paediatric Drug Development
12. Safe lists for medications in pregnancy: inadequate evidence base and inconsistent guidance from Web-based information, 2011
13. Perspectives in risk assessment—Drug and vaccine safety
14. Pediatric cardiovascular safety: Challenges in drug and device development and clinical application
15. Monitoring for teratogenic signals: Pregnancy registries and surveillance methods
16. Improving Access to FDA Reviews and Documents
17. Postnatal Developmental Milestones
18. Gene Expression during Development of the Osteoblast Phenotype: An Integrated Relationship of Cell Growth to Differentiation
19. Evidence-based pregnancy testing in clinical trials: Recommendations from a multi-stakeholder development process
20. The new FDA labeling rule: impact on prescribing rheumatological medications during pregnancy
21. Antiemetic use among pregnant women in the United States: the escalating use of ondansetron
22. Reply: To PMID 24881821
23. Assessing congenital malformation risk from medications used in pregnancy: The contribution of NBDPS in pregnancy labeling of prescription drug products
24. Reply
25. Assessment of health risks resulting from early-life exposures: Are current chemical toxicity testing protocols and risk assessment methods adequate?
26. Reevaluation of the Embryonic Stem Cell Test
27. Current and future needs for developmental toxicity testing
28. Value of juvenile animal studies
29. Essential fatty acid supplementation of DHA and ARA and effects on neurodevelopment across animal species: a review of the literature
30. Juvenile animal studies and pediatric drug development retrospective review: use in regulatory decisions and labeling
31. Effect of sodium warfarin on vitamin K-dependent proteins and skeletal development in the rat fetus
32. Effect of caffeine on parameters of osteoblast growth and differentiation of a mineralized extracellular matrix in vitro
33. Comparative juvenile safety testing of new therapeutic candidates: Relevance of laboratory animal data to children
34. Timing of Implantation and Closure of the Palatal Shelf in New Zealand White and Japanese White Rabbits
35. Pre‐ and postnatal development studies of lasofoxifene, a selective estrogen receptor modulator (SERM), in Sprague–Dawley rats
36. Communicating risks during pregnancy: A workshop on the use of data from animal developmental toxicity studies in pregnancy labels for drugs
37. Concern over decreased training in embryology and developmental/reproductive toxicology
38. Species comparison of postnatal bone growth and development
39. Comparison of developmental toxicology of aspirin (Acetylsalicylic Acid) in rats using selected dosing paradigms
40. NSAIDs and developmental toxicity
41. Analysis of the nonsteroidal anti‐inflammatory drug literature for potential developmental toxicity in rats and rabbits
42. Differential effects of warfarin on mRNA levels of developmentally regulated vitamin K dependent proteins, osteocalcin, and matrix Gla protein in vitro
43. 2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibits differentiation of normal diploid rat osteoblasts in vitro
44. Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes
45. Downregulation of histone H4 gene transcription during postnatal development in transgenic mice and at the onset of differentiation in transgenically derived calvarial osteoblast cultures
46. Developmental expression and hormonal regulation of the rat matrix GLA protein (MGP) gene in chondrogenesis and osteogenesis
47. No Change in Spontaneous Behavior of Rats after Acute Oral Doses of Aspartame, Phenylalanine, and Tyrosine
48. Gene expression during endochondral bone development: Evidence for coordinate expression of transforming growth factor β1 and collagen type I
49. Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix
50. No Change in Spontaneous Behavior of Rats after Acute Oral Doses of Aspartame, Phenylalanine, and Tyrosine.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.